# OnCo record newcastle-cancer-centre (institution). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/institutions/newcastle-cancer-centre/>
  a schema:MedicalOrganization ;
  onco:kind "institution" ;
  schema:identifier "newcastle-cancer-centre" ;
  schema:name "Newcastle Cancer Centre / Northern Centre for Cancer Care"@en ;
  schema:alternateName "Newcastle upon Tyne Hospitals NHS Foundation Trust"@en, "Freeman Hospital"@en, "Newcastle University Centre for Cancer"@en ;
  schema:description "Newcastle's cancer centre serves the North East and Cumbria; its chemists and pharmacologists discovered rucaparib, the first PARP inhibitor to reach patients, and Ruth Plummer led its first-in-human trial in 2003, while the Wolfson centre leads medulloblastoma research."@en ;
  schema:url <https://onco.cc/institutions/newcastle-cancer-centre/>, <https://www.newcastle-hospitals.nhs.uk/services/cancer-services/> ;
  schema:dateModified "2026-09-09"^^xsd:date ;
  schema:citation <https://www.newcastle-hospitals.nhs.uk/services/cancer-services/>, <https://www.ncl.ac.uk/cancer/> ;
  schema:addressCountry "GB" ;
  schema:addressLocality "Newcastle upon Tyne" ;
  schema:latitude "54.999"^^xsd:decimal ;
  schema:longitude "-1.616"^^xsd:decimal ;
  onco:cancers <https://onco.cc/cancers/ovarian/>, <https://onco.cc/cancers/neuroblastoma/>, <https://onco.cc/cancers/all-leukemia/>, <https://onco.cc/cancers/glioblastoma/>, <https://onco.cc/cancers/pancreatic/>, <https://onco.cc/cancers/colorectal/>, <https://onco.cc/cancers/nsclc/>, <https://onco.cc/cancers/lung-cancer/>, <https://onco.cc/cancers/skin-cancer/>, <https://onco.cc/cancers/basal-cell-carcinoma/> ;
  onco:sections <https://onco.cc/fronts/targeted-therapy/>, <https://onco.cc/fronts/drug-discovery/> ;
  onco:technologies <https://onco.cc/technologies/parp-inhibitor/>, <https://onco.cc/technologies/synthetic-lethality-approaches/>, <https://onco.cc/technologies/ai-drug-design/> ;
  onco:targets <https://onco.cc/targets/parp/>, <https://onco.cc/targets/brca/> ;
  onco:institutions <https://onco.cc/institutions/cruk/> ;
  onco:terms <https://onco.cc/terms/synthetic-lethality/> ;
  onco:trials <https://onco.cc/trials/capp2/> ;
  onco:people <https://onco.cc/people/ruth-plummer/>, <https://onco.cc/people/steven-clifford/>, <https://onco.cc/people/graham-jackson/>, <https://onco.cc/people/john-burn/>, <https://onco.cc/people/alastair-greystoke/> .